Videos
Alli Antar
Researcher, Baylor College of Medicine
Positions
- Current:
-
- Researcher, Baylor College of Medicine, Houston, Texas, United States
Education
- PhD, Molecular Physiology and Biophysics, Vanderbilt University
Interests
Links
Publications
-
Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Glucocorticoids, which are well established to regulate body fat mass distribution, adipocyte lipolysis, hepatic gluconeogenesis, and hepatocyte VLDL secretion, are speculated to play a role in the pa…
Authors: Alli M Nuotio-Antar, David L Hachey, Alyssa H Hasty
Source: American journal of physiology. Endocrinology and metabolism 2007 Dec
View Full Text -
Quantitation and cellular localization of 11beta-HSD1 expression in murine thymus.
11beta-hydroxysteroid dehydrogenase type I (11beta-HSD1), an NADPH-dependent reductase, functions in intact cells to convert inactive 11-keto metabolites of glucocorticoids into biologically active gl…
Authors: Alli M Nuotio-Antar, Alyssa H Hasty, William J Kovacs
Source: The Journal of steroid biochemistry and molecular biology 2006 May
View Full Text -
Plasma insulin levels predict atherosclerotic lesion burden in obese hyperlipidemic mice.
Despite a clear association between obesity, insulin resistance and atherosclerosis in humans, to date, no animal models have been described in which insulin resistance is associated with atherosclero…
Authors: Marnie L Gruen, Viswanathan Saraswathi, Alli M Nuotio-Antar, Michelle R Plummer, Kimberly R Coenen, Alyssa H Hasty
Source: Atherosclerosis 2006 May
View Full Text
